What is Enhatch?
Enhatch operates at the forefront of digital surgery, offering a comprehensive virtual planning platform tailored for orthopedic and spine procedures. The company's software suite facilitates seamless collaboration between surgical teams, biomedical engineers, and device representatives, effectively digitizing the preoperative workflow. By integrating directly with leading additive manufacturing partners such as 3D Systems, Enhatch ensures that patient-specific case proposals are not only accurate but also ready for rapid production. This end-to-end solution addresses the critical need for precision in complex surgeries while maintaining strict adherence to medical data security standards, positioning the company as an essential partner for healthcare providers seeking to optimize patient outcomes through personalized medicine.
How much funding has Enhatch raised?
Enhatch has raised a total of $420K across 3 funding rounds:
Other Financing Round
$20K
Other Financing Round
$250K
Debt
$150K
Other Financing Round (2012): $20K with participation from Blueprint Health
Other Financing Round (2012): $250K led by Peter Verrillo
Debt (2020): $150K supported by PPP
Key Investors in Enhatch
Blueprint Health
Blueprint Health is a prominent healthcare accelerator focused on nurturing entrepreneurs to develop innovative healthcare IT companies through intensive mentorship and strategic network access.
Peter Verrillo
An individual investor providing strategic backing to support the early-stage development and operational scaling of medical technology ventures.
PPP
Public-Private Partnership
What's next for Enhatch?
With the recent capital deployment, Enhatch is well-positioned to scale its platform capabilities and deepen its penetration within the global orthopedic market. The strategic focus will likely shift toward enhancing interoperability with broader hospital information systems and expanding the reach of its 3D printing integration network. As the demand for patient-specific surgical solutions continues to rise, Enhatch is poised to leverage its late-stage funding to solidify its competitive moat, potentially exploring new therapeutic areas beyond orthopedics and spine surgery. The company's ability to maintain secure, efficient workflows will remain a cornerstone of its growth strategy as it navigates the complexities of the medical device regulatory landscape and seeks to capture a larger share of the digital surgery market.
See full Enhatch company page
